Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

317.45 -2.21 (-0.69%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
41 42 Next >
Amgen's Q4 Sales Remain Flat As Its Biggest Product Flounders
Amgen Inc's (NASDAQ: AMGN) Q4 revenues incr 
Via Benzinga
Failed Experiments
Amazon had around $470 billion in revenue in 2021. Was it worth it to pick up $14.5 billion in revenue in online grocery sales? 
Via Talk Markets
What's Going On With Amgen Stock During Today's After-Hours Session
Shares of Amgen Inc. (NASDAQ: AMGN) stepped higher following the release of its Q4 earnings report showing an EPS beat and a slight miss on sales. The company reported, on a GAAP... 
Via Benzinga
Amgen: Q4 Earnings Insights
Amgen (NASDAQ:AMGN) reported its Q4 earnings results on Monday, February 7, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Amgen beat estimated earnings by 5.83%,... 
Via Benzinga
Amgen Stock Remains In Limbo As Its Biggest Product Flounders
Sales of Enbrel fell, in part, because Amgen's Otezla gained a new approval. 
Via Investor's Business Daily
(AMGN) - Analyzing Amgen Inc's Short Interest
Amgen Inc's (NASDAQ:AMGN) short percent of float has risen 5.91% since last its last report. The company recently reported that it has 12.07 million shares sold short, which is 2.... 
Via Benzinga
Price To Earnings Ratio Insights For Amgen
  
Via Benzinga
Picking Up Steam
Friday’s close marked 23 trading days since the S&P 500’s last closing record high, and during that span, the S&P 500 is down 6.2%. 
Via Talk Markets
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
U.S. stock futures traded lower in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session. 
Via Talk Markets
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
Pre-open movers 
Via Benzinga
5 Stocks To Watch For February 7, 2022
Some of the stocks that may grab inve3stor focus today are: Wall Street expects Tyson Foods, Inc. (NYSE: TSN) to report quarterly earnings at $1.90 per share on revenue of $12.18 billion after the... 
Via Benzinga
A Preview Of Amgen's Earnings
Amgen (NASDAQ:AMGN) is set to give its latest quarterly earnings report on Monday, 2022-02-07. Here's what investors need to know before the announcement. Analysts estimate that Amgen will likely... 
Via Benzinga
Earnings Scheduled For February 7, 2022
Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report quarterly earnings at $0.10 per share on revenue of $31.60 million. 
Via Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
Photo by Diana Polekhina on Unsplash 
Via Benzinga
Will Moderna Sidestep The Looming Sales Cliff After FDA Approves Covid Shot?
Currently, analysts expect Moderna sales to drop off after 2022. 
Via Investor's Business Daily
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
Dogs of the Dow Dominating
A little more than half of the Dogs are in the black year to date compared to only three (of twenty) non-dogs that are positive. 
Via Talk Markets
Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch
As investor appetite for high-growth stocks begins to decrease in the new year, dividend stocks will likely to gain traction in 2022. 
Via InvestorPlace
Is Amgen (AMGN) A Good Stock To Buy?
The pharmaceutical sector has a lot of big companies that pay a growing dividend, and AMGN is one of them. 
Via Talk Markets
CNBC's Final Trades: Marvell, Amgen, Viper Energy, JPMorgan And This Tech Major That Is 'Way Too Cheap'
On CNBC’s “Halftime Report Final T... 
Via Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
Photo by Towfiqu barbhuiya on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice... 
Via Benzinga
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
Amgen's Lumakras Approved In Japan For Pretreated Lung Cancer Patients
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent non-small... 
Via Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In... 
Via Benzinga
3 Pharma Stocks Yielding Over 3%
The Pharma industry faced headwinds in 2021 as hospitals delayed procedures and elective surgeries. 
Via Talk Markets
Inflation 2022 – Week In Review
Arguably, the number one concern in 2022 for most investors, consumers, and businesses is inflation. Inflation is rising in the US and globally, and recent reports this week were not good. 
Via Talk Markets
Blue-Chip Bank Earnings, Retail Data Drag Dow Lower
Within the last hour of trading, the S&P 500 and Nasdaq managed to eke out slight gains. All three major indexes fell for the week. 
Via Talk Markets
How Is The Market Feeling About Amgen Inc?
Amgen Inc's (NASDAQ:AMGN) short percent of float has fallen 11.74% since last its last report. The company recently reported that it has 11.40 million shares sold short, which is... 
Via Benzinga
A Look Into Amgen's Price Over Earnings
Right now, Amgen Inc. (NASDAQ:AMGN) share price is at $229.33, after a 0.45% drop. Over the past month, the stock went up by 7.29%, but over the past year, it... 
Via Benzinga
Europe Approves Amgen's KRAS-Targeted Lung Cancer Therapy
The European Commission (EC) has granted conditional marketing authorization to Amgen Inc's (NASDAQ: AMGN) Lumykras (sotorasib), a KRASG12C inhibitor, for... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
41 42 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.